UNSPSC 85893258: High dose rate (hdr) brachytherapy of duodenum using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of duodenum using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DD1299Z

UNSPSC 85893258 High dose rate (hdr) brachytherapy of duodenum using iodine 125 (i-125) is a Commodity code that nominally describes a specialized cancer treatment modality, but the recent state and local procurement activity under this code shows minimal alignment with that clinical scope. The single recent opportunity identified — Santa Clara County Health System's RFQ for temporary health professional staffing services — does not involve brachytherapy, duodenal intervention, or radiation oncology; instead it solicits qualified vendors to supply temporary clinical staff across thirteen ancillary health professional categories including audiology, cardiology, diagnostic imaging, gastroenterology, orthopedics, and surgical services. This mismatch suggests the code may be mistagged in the county's procurement system, or it is seeing little genuine activity in its intended therapeutic domain.

Santa Clara County Health System posted the temporary staffing RFQ (RFSQHHSFY270052) on July 7, 2026, with proposals due October 7, 2026. The solicitation establishes a non-exclusive, multiple-award qualified vendor pool with no guaranteed volume; the Health System may maintain the list for five years and contract with selected vendors as operational needs arise. Proposers self-select which of the thirteen clinical categories to pursue without penalty for specialty focus. Given the disconnect between the UNSPSC code's nominal scope and the actual opportunity, this code shows little relevant recent activity for firms pursuing brachytherapy services, radiation oncology support, or specialized gastrointestinal cancer treatment contracting with state and local health systems.